Gupta A, Neogi R, Mukherjea M, Mukhopadhyay A, Roychoudhury S, Senapati A, Gangopadhyay P K, Ray Kunal
Human Genetics & Genomics Division, Indian Institute of Chemical Biology, Jadavpur, Kolkata, India.
Indian J Med Res. 2003 Nov;118:208-14.
BACKGROUND & OBJECTIVES: Wilson disease (WD) is an autosomal recessive disorder caused by defects in ATP7B gene located in chromosome 13q14, and manifested as hepatolenticular degeneration as a result of accumulation of copper. No information on the mutation in the ATP7B gene and haplotypes using linked markers is available for WD patients in India. Hence, the present study was undertaken to identify, by a PCR-based molecular diagnostic test, presymptomatic siblings of WD affected individuals in families with multiple offspring.
Genomic DNA was prepared from the peripheral blood of the patients, siblings and his/her first degree relatives. The repeat-markers flanking WD locus were amplified by PCR using fluorescent labeled primers. Amplified DNA fragments were analyzed by polyacrylamide gel electrophoresis in ABI 377 DNA sequencing system. Genotypes of the samples were determined using Genescan software. Haplotypes were determined based on segregation of the alleles in the families under study.
Among 15 WD affected families with multiple children, 4 cases were identified where younger siblings shared same genotype as the patient at all three markers analyzed. Further, eight different haplotypes were detected in the four patients.
INTERPRETATION & CONCLUSION: The siblings of the WD patients carrying the same genotype at the markers linked to WD locus were presymptomatically diagnosed individuals. Presence of eight different haplotypes in the four patients suggested mutational heterogeneity at the WD locus. The test helps clinicians for therapeutic intervention in suspect WD cases by copper chelating agents prior to manifestation of overt clinical symptoms.
威尔逊病(WD)是一种常染色体隐性疾病,由位于13q14染色体上的ATP7B基因缺陷引起,因铜蓄积而表现为肝豆状核变性。印度的WD患者尚无关于ATP7B基因突变及使用连锁标记的单倍型的信息。因此,本研究采用基于聚合酶链反应(PCR)的分子诊断试验,对多子女家庭中WD患者的无症状同胞进行鉴定。
从患者、其同胞及其一级亲属的外周血中提取基因组DNA。使用荧光标记引物通过PCR扩增WD基因座侧翼的重复标记。扩增的DNA片段在ABI 377 DNA测序系统中通过聚丙烯酰胺凝胶电泳进行分析。使用Genescan软件确定样本的基因型。根据所研究家庭中等位基因的分离情况确定单倍型。
在15个有多个子女的WD患病家庭中,有4例被鉴定出其年幼的同胞在所分析的所有三个标记上与患者具有相同的基因型。此外,在这4例患者中检测到8种不同的单倍型。
在与WD基因座连锁的标记上携带相同基因型的WD患者的同胞为无症状诊断个体。4例患者中存在8种不同的单倍型,提示WD基因座存在突变异质性。该检测有助于临床医生在明显临床症状出现之前,对疑似WD病例使用铜螯合剂进行治疗干预。